The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

Net profit likely fell 90 percent to 93 percent to between CNY86 million and CNY120 million (USD11.7 million to USD16.4 ...

ULAN BATOR, Jan. 24 (Xinhua) -- Mongolia has so far vaccinated at least 20,682 children aged 11 against human papillomavirus (HPV) as part of a nationwide campaign, according to a report released on ...

Basu Chatterjee’s legal drama Ek Ruka Hua Faisla (A Paused Decision), itself an adaptation of a Hollywood film, has achieved ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

A Shanghai lawmaker is calling for free human papillomavirus vaccinations (HPV) for girls in primary and middle school. Cervical cancer is the most prevalent female cancer in the world. In 2020, a ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in a key market where demand has been falling among ...

The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV vaccine, after US pharmaceutical giant Merck announced its quadrivalent HPV ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, ...

“Since first approval, our HPV vaccines have helped protect over 50 million females in China from certain HPV-related cancers and diseases. With this expanded approval, we look forward to ...